Skip to content

Impact of Renal Anatomy on Shock Wave Lithotripsy Outcomes for Lower Pole Kidney Stones

Impact of Renal Anatomy on Shock Wave Lithotripsy Outcomes for Lower Pole Kidney Stones: Results From a Prospective Multifactorial Analysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01589484
Enrollment
104
Registered
2012-05-02
Start date
2012-04-30
Completion date
2014-12-31
Last updated
2015-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Calculi, Urinary Lithiasis, Urolithiasis

Keywords

Tomography, Urinary Lithiasis, Kidney Calculi

Brief summary

Kidney stone disease affects almost 10% of overall population, often requiring a surgical intervention. Currently, shock wave lithotripsy is considered a first-line treatment option for patients suffering from symptomatic kidney stones smaller than 2.0 cm, providing reasonable stone-free rate. Actually, the outcomes from SWL vary largely due to several factors including stone burden, stone density, stone-skin distance (SSD), and patient's body habitus. Furthermore, the imaging exam modality (i.e. ultrasound versus computed tomography scan) performed to assess the presence of residual fragments also impacts on SWL outcome analysis. We aim to perform a well-controlled prospective evaluation of all variables that may impact on fragmentation and clearance of lower pole calculi after SWL. These variables are assessed exclusively by a noncontrast computed tomography scan (NCCT), eliminating the necessity of an intravenous urography to study renal collecting system anatomy; an imaging exam that is not routinely performed anymore for kidney stone patients.

Detailed description

Variables in study: * Age, gender, body mass index (BMI), and waist abdominal circumference * Noncontrast computed tomography scan (NCCT): stone density (average of 3 measurements), stone size, stone area, skin to stone distance (average of 3 measurements: zero, 45o and 90o), and collecting system anatomy: infundibular length, width, and height, and infundibulopelvic angle Study design: All patients will be submitted to a noncontrast computed tomography scan before to SWL. A radiologist with expertise in urolithiasis will evaluate all exams. Patients will be submitted to SWL under the following conditions: outpatient, general anesthesia, 3000 impulses, rate of 90/min, discharged from hospital in the same day with alpha-blocker (doxazosin) during 30 days. Patients will be followed up as follow: * One week after SWL: medical visit To evaluate complications such as pain, dysuria, hematuria, steinstrasse, visit to the emergency department. * 12 weeks after SWL: new NCCT scan To evaluate kidney stones fragmentation and clearance. Univariate (Student's T test) and multivariate analysis (multiple logistic regression) will be done to assess the impact of patient's corporal habitus (BMI and abdominal waist circumference), stone characteristics (size, area, density and SSD), and renal collecting system anatomy (infundibular length, width and height, and infundibulopelvic angle) on SWL outcomes (fragmentation and stone-free rates).

Interventions

DEVICESWL - Compact Delta Dornier Med Tech

All patients will be submitted to a noncontrast computed tomography before to SWL. Patients will be submitted to SWL under the following conditions: outpatient, general anesthesia, 3000 impulses, rate of 90/min, discharged from hospital in the same day with alpha-blocker (doxazosin) during 30 days.

Sponsors

University of Sao Paulo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\> 17 year-old. Symptomatic single stone of 5 to 20mm located in the lower pole of the kidney. Informed consent signed.

Exclusion criteria

Patients with congenital kidney abnormalities (i.e. horseshoes kidney, pelvic kidney, ectopic kidney), patients with ureteral stent (i.e. Double J stent) in the ipsilateral kidney of the stone in study, patients with chronic kidney disease (glomerular filtration rate \<60 mL/minute/1.73m2 measured by the equation Modification of Diet in Renal Disease), and patients with absolute contraindication to SWL (i.e. coagulopathy, pregnancy, urinary tract infection, or abdominal aneurysm \>4.0cm).

Design outcomes

Primary

MeasureTime frameDescription
Stone Clearance12 weeks after SWLAfter 12 weeks, all patients will be submitted to a new NCCT scan to evaluate stone fragmentation and stone clearance.

Secondary

MeasureTime frameDescription
SWL Complications12 weeks after SWLSecondary endpoint will be SWL complications (i.e. pain, hematuria, urinary tract infection, Steinstrasse)

Countries

Brazil

Participant flow

Participants by arm

ArmCount
Shockwave Lithotripsy (SWL)
One hundred patients fulfilled the inclusion and exclusion criteria and were enrolled in this study. Mean age and BMI were 47.1 years and 28.0 Kg/m2, respectively. Half of patients had their stone localized in the right kidney. Mean stone size was 9.1mm and mean stone density was 795 HU.
100
Total100

Baseline characteristics

CharacteristicShockwave Lithotripsy (SWL)
Age, Continuous47.1 years
STANDARD_DEVIATION 12.5
BMI28.0 Kg/m2
STANDARD_DEVIATION 4.7
Region of Enrollment
Brazil
100 participants
Sex: Female, Male
Female
50 Participants
Sex: Female, Male
Male
50 Participants
Waist abdominal circumference94.1 cm
STANDARD_DEVIATION 12.7

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 104
serious
Total, serious adverse events
0 / 104

Outcome results

Primary

Stone Clearance

After 12 weeks, all patients will be submitted to a new NCCT scan to evaluate stone fragmentation and stone clearance.

Time frame: 12 weeks after SWL

Population: Fragmentation

ArmMeasureValue (NUMBER)
Primary EndointStone Clearance76 participants
Secondary

SWL Complications

Secondary endpoint will be SWL complications (i.e. pain, hematuria, urinary tract infection, Steinstrasse)

Time frame: 12 weeks after SWL

ArmMeasureValue (NUMBER)
Primary EndointSWL Complications7 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026